Go to Medications | Go to Definition
Lab Results, US
| Associated Problem ID | Associated Problem Name | Data Domain | Coding System | Coding System Version | Lab Primary Key | Clinical Category | Result Name | LOINC Code | LOINC Component | LOINC Property | LOINC Time | LOINC System | LOINC Scale | LOINC Method | LOINC Long Name | Common US Use | Common Intl Use | Also Consider | LOINC Status | External Comments | % Consensus Agreement | PCM Status | Release Change Comments | PCM Version First Released | PCM Version Last Updated |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.008 | Dyslipidemia | Labs | LOINC | 267,00 | 1.000.179 | Kidney Function Tests | Creatinine | 2160-0 | Creatinine | MCnc | Pt | Ser/Plas | Qn | Creatinine [Mass/volume] in Serum or Plasma | X | ACTIVE | 100% | Active | 102,00 | ||||||
| 1.000.181 | Kidney Function Tests | Creatinine | 14682-9 | Creatinine | SCnc | Pt | Ser/Plas | Qn | Creatinine [Moles/volume] in Serum or Plasma | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
| 1.000.182 | Kidney Function Tests | Creatinine Serum Plasma or Blood | 77140-2 | Creatinine | SCnc | Pt | Ser/Plas/Bld | Qn | Creatinine [Moles/volume] in Serum, Plasma or Blood | ACTIVE | Use only for a specific International laboratory system. US use discouraged. | 100% | Active | 102,00 | |||||||||||
| 1.000.253 | Kidney Function Tests | Creatinine Blood | 38483-4 | Creatinine | MCnc | Pt | Bld | Qn | Creatinine [Mass/volume] in Blood | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
| 1.000.254 | Kidney Function Tests | Creatinine Arterial | 21232-4 | Creatinine | MCnc | Pt | BldA | Qn | Creatinine [Mass/volume] in Arterial blood | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
| 1.000.255 | Kidney Function Tests | Creatinine Blood | 59826-8 | Creatinine | SCnc | Pt | Bld | Qn | Creatinine [Moles/volume] in Blood | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
| 1.000.175 | Kidney Function Tests | Estimated Creatinine Clearance by Cockcroft-Gault | 35591-7 | Creatinine renal clearance.predicted | VRat | Pt | Ser/Plas | Qn | Cockcroft-Gault formula | Creatinine renal clearance predicted by Cockcroft-Gault formula | X | ACTIVE | 100% | Active | 102,00 | ||||||||||
| 1.000.176 | Kidney Function Tests | Estimated Creatinine Clearance by Cockcroft-Gault BSA | 35592-5 | Creatinine renal clearance/1.73 sq M.predicted | ArVRat | Pt | Ser/Plas | Qn | Cockcroft-Gault formula, BSA formula | Creatinine renal clearance/1.73 sq M.predicted by Cockcroft-Gault formula, BSA formula | X | ACTIVE | 100% | Active | 102,00 | ||||||||||
| 1.000.178 | Kidney Function Tests | Estimated Creatinine Clearance females by Cockcroft-Gault BSA | 50380-5 | Creatinine renal clearance/1.73 sq M.predicted.female | ArVRat | Pt | Ser/Plas | Qn | Cockcroft-Gault formula, BSA formula | Creatinine renal clearance/1.73 sq M.predicted among females by Cockcroft-Gault formula, BSA formula | X | ACTIVE | 100% | Active | 102,00 | ||||||||||
| 1.000.177 | Kidney Function Tests | Estimated Creatinine Clearance males by Cockcroft-Gault BSA | 50381-3 | Creatinine renal clearance/1.73 sq M.predicted.male | ArVRat | Pt | Ser/Plas | Qn | Cockcroft-Gault formula, BSA formula | Creatinine renal clearance/1.73 sq M.predicted among males by Cockcroft-Gault formula, BSA formula | X | ACTIVE | 100% | Active | 102,00 | ||||||||||
| 1.000.250 | Kidney Function Tests | Creatinine Pre Contrast | 72271-0 | Creatinine^pre contrast | MCnc | Pt | Ser/Plas | Qn | Creatinine [Mass/volume] in Serum or Plasma --pre contrast | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
| 1.000.251 | Kidney Function Tests | Creatinine Pre Dialysis | 11042-9 | Creatinine^pre dialysis | MCnc | Pt | Ser/Plas | Qn | Creatinine [Mass/volume] in Serum or Plasma --pre dialysis | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
| 1.000.252 | Kidney Function Tests | Creatinine Pre Dialysis | 51619-5 | Creatinine^pre dialysis | SCnc | Pt | Ser/Plas | Qn | Creatinine [Moles/volume] in Serum or Plasma --pre dialysis | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
| 1.000.011 | Kidney Function Tests | Deprecated eGFR by Schwartz | 50383-9 | Glomerular filtration rate.predicted | VRat | Pt | Ser/Plas | Qn | Creatinine-based formula (Schwartz) | Deprecated Glomerular filtration rate/1.73 sq M.predicted in 24 hour by Creatinine-based formula (Schwartz) | DEPRECATED | 100% | Active | 102,00 | |||||||||||
| 1.000.000 | Kidney Function Tests | eGFR | 69405-9 | Glomerular filtration rate/1.73 sq M.predicted | ArVRat | Pt | Ser/Plas/Bld | Qn | Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
| 1.000.001 | Kidney Function Tests | eGFR by CKD-EPI | 62238-1 | Glomerular filtration rate/1.73 sq M.predicted | ArVRat | Pt | Ser/Plas/Bld | Qn | Creatinine-based formula (CKD-EPI) | Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI) | X | X | ACTIVE | 100% | Active | 102,00 | |||||||||
| 1.000.004 | Kidney Function Tests | eGFR Blood by MDRD (Discouraged) | 76633-7 | Glomerular filtration rate/1.73 sq M.predicted | ArVRat | Pt | Bld | Qn | Creatinine-based formula (MDRD) | Glomerular filtration rate/1.73 sq M.predicted by Creatinine-based formula (MDRD) in Blood | DISCOURAGED | 100% | Active | 102,00 | |||||||||||
| 1.000.005 | Kidney Function Tests | eGFR by MDRD (Discouraged) | 33914-3 | Glomerular filtration rate/1.73 sq M.predicted | ArVRat | Pt | Ser/Plas | Qn | Creatinine-based formula (MDRD) | Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) | DISCOURAGED | 100% | Active | 102,00 | |||||||||||
| 1.000.006 | Kidney Function Tests | eGFR by MDRD | 77147-7 | Glomerular filtration rate/1.73 sq M.predicted | ArVRat | Pt | Ser/Plas/Bld | Qn | Creatinine-based formula (MDRD) | Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD) | X | X | ACTIVE | 100% | Active | 102,00 | |||||||||
| 1.000.012 | Kidney Function Tests | eGFR by Schwartz | 50384-7 | Glomerular filtration rate/1.73 sq M.predicted | ArVRat | Pt | Ser/Plas/Bld | Qn | Creatinine-based formula (Schwartz) | Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (Schwartz) | X | ACTIVE | 100% | Active | 102,00 | ||||||||||
| 1.000.013 | Kidney Function Tests | eGFR by Cystatin | 50210-4 | Glomerular filtration rate/1.73 sq M.predicted | ArVRat | Pt | Ser/Plas/Bld | Qn | Cystatin-based formula | Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Cystatin-based formula | X | ACTIVE | 100% | Active | 102,00 | ||||||||||
| 1.000.002 | Kidney Function Tests | eGFR by CKD-EPI in blacks | 88293-6 | Glomerular filtration rate/1.73 sq M.predicted.black | ArVRat | Pt | Ser/Plas/Bld | Qn | Creatinine-based formula (CKD-EPI) | Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI) | X | ACTIVE | 100% | Active | 102,00 | ||||||||||
| 1.000.007 | Kidney Function Tests | eGFR by MDRD in blacks | 48643-1 | Glomerular filtration rate/1.73 sq M.predicted.black | ArVRat | Pt | Ser/Plas/Bld | Qn | Creatinine-based formula (MDRD) | Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD) | X | X | ACTIVE | 100% | Active | 102,00 | |||||||||
| 1.000.008 | Kidney Function Tests | eGFR by MDRD in females | 50044-7 | Glomerular filtration rate/1.73 sq M.predicted.female | ArVRat | Pt | Ser/Plas/Bld | Qn | Creatinine-based formula (MDRD) | Glomerular filtration rate/1.73 sq M.predicted among females [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD) | X | ACTIVE | 100% | Active | 102,00 | ||||||||||
| 1.000.009 | Kidney Function Tests | eGFR by MDRD in males | 70969-1 | Glomerular filtration rate/1.73 sq M.predicted.male | ArVRat | Pt | Ser/Plas/Bld | Qn | Creatinine-based formula (MDRD) | Glomerular filtration rate/1.73 sq M.predicted among males [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD) | X | ACTIVE | 100% | Active | 102,00 | ||||||||||
| 1.000.003 | Kidney Function Tests | eGFR by CKD-EPI in non-blacks | 88294-4 | Glomerular filtration rate/1.73 sq M.predicted.non black | ArVRat | Pt | Ser/Plas/Bld | Qn | Creatinine-based formula (CKD-EPI) | Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI) | X | ACTIVE | 100% | Active | 102,00 | ||||||||||
| 1.000.010 | Kidney Function Tests | eGFR by MDRD in non-blacks | 48642-3 | Glomerular filtration rate/1.73 sq M.predicted.non black | ArVRat | Pt | Ser/Plas/Bld | Qn | Creatinine-based formula (MDRD) | Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD) | X | X | ACTIVE | 100% | Active | 102,00 | |||||||||
| 1.000.423 | Liver Function Tests | ALT (SGPT) Blood | 76625-3 | Alanine aminotransferase | CCnc | Pt | Bld | Qn | Alanine aminotransferase [Enzymatic activity/volume] in Blood | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
| 1.000.425 | Liver Function Tests | ALT (SGPT) | 1742-6 | Alanine aminotransferase | CCnc | Pt | Ser/Plas | Qn | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | X | X | ACTIVE | 100% | Active | 102,00 | ||||||||||
| 1.000.426 | Liver Function Tests | ALT (SGPT) Without P5'P | 1744-2 | Alanine aminotransferase | CCnc | Pt | Ser/Plas | Qn | No addition of P-5'-P | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by No addition of P-5'-P | X | X | ACTIVE | 100% | Active | 102,00 | |||||||||
| 1.000.427 | Liver Function Tests | ALT (SGPT) by P5'P | 1743-4 | Alanine aminotransferase | CCnc | Pt | Ser/Plas | Qn | With P-5'-P | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P | X | ACTIVE | 100% | Active | 102,00 | ||||||||||
| 1.000.428 | Liver Function Tests | ALT (SGPT) Serum Plasma or Blood | 77144-4 | Alanine aminotransferase | CCnc | Pt | Ser/Plas/Bld | Qn | Alanine aminotransferase [Enzymatic activity/volume] in Serum, Plasma or Blood | ACTIVE | Use only for a specific International laboratory system. US use discouraged. | 100% | Active | 102,00 | |||||||||||
| 1.006.104 | Lipids | Deprecated Apolipoprotein B | 6772-8 | Apolipoprotein B | MCnc | Pt | Ser/Plas | Qn | Deprecated Apolipoprotein B [Mass/volume] in Serum or Plasma | DEPRECATED | 100% | Active | 102,00 | ||||||||||||
| 1.006.105 | Lipids | Apolipoprotein B | 1884-6 | Apolipoprotein B | MCnc | Pt | Ser/Plas | Qn | Apolipoprotein B [Mass/volume] in Serum or Plasma | X | X | ACTIVE | 100% | Active | 102,00 | ||||||||||
| 1.006.106 | Lipids | Apolipoprotein B | 76482-9 | Apolipoprotein B | SCnc | Pt | Ser/Plas | Qn | Apolipoprotein B [Moles/volume] in Serum or Plasma | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
| 1.006.107 | Lipids | Apolipoprotein B 100 | 1871-3 | Apolipoprotein B-100 | MCnc | Pt | Ser/Plas | Qn | Apolipoprotein B-100 [Mass/volume] in Serum or Plasma | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
| 1.006.108 | Lipids | Apolipoprotein B 150 | 1872-1 | Apolipoprotein B-150 | MCnc | Pt | Ser/Plas | Qn | Apolipoprotein B-150 [Mass/volume] in Serum or Plasma | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
| 1.006.109 | Lipids | Apolipoprotein B 48 | 1873-9 | Apolipoprotein B-48 | MCnc | Pt | Ser/Plas | Qn | Apolipoprotein B-48 [Mass/volume] in Serum or Plasma | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
| 1.000.306 | Lipids | Deprecated Total Cholesterol | 2565-0 | Cholesterol | MCnc | Pt | Ser/Plas | Qn | Deprecated Cholesterol [Mass/volume] in Serum or Plasma | DEPRECATED | 100% | Active | 102,00 | ||||||||||||
| 1.000.307 | Lipids | Total Cholesterol | 2093-3 | Cholesterol | MCnc | Pt | Ser/Plas | Qn | Cholesterol [Mass/volume] in Serum or Plasma | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
| 1.000.308 | Lipids | Total Cholesterol Ultracentrifuged | 48620-9 | Cholesterol | MCnc | Pt | Ser/Plas.ultracentrifugate | Qn | Cholesterol [Mass/volume] in Serum or Plasma ultracentrifugate | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
| 1.000.310 | Lipids | Total Cholesterol | 14647-2 | Cholesterol | SCnc | Pt | Ser/Plas | Qn | Cholesterol [Moles/volume] in Serum or Plasma | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
| 1.000.311 | Lipids | Deprecated Total Cholesterol Blood | 50339-1 | Cholesterol | MCnc | Pt | Bld | Qn | Deprecated Cholesterol [Mass/volume] in blood | DEPRECATED | 100% | Active | 102,00 | ||||||||||||
| 1.000.327 | Lipids | Deprecated HDL Cholesterol | 2086-7 | Cholesterol.in HDL | MCnc | Pt | Ser/Plas | Qn | Deprecated Cholesterol.in HDL [Mass/volume] in Serum or Plasma | DEPRECATED | 100% | Active | 102,00 | ||||||||||||
| 1.000.328 | Lipids | HDL Cholesterol | 2085-9 | Cholesterol.in HDL | MCnc | Pt | Ser/Plas | Qn | Cholesterol in HDL [Mass/volume] in Serum or Plasma | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
| 1.000.330 | Lipids | HDL Cholesterol Ultracentrifuged | 18263-4 | Cholesterol.in HDL | MCnc | Pt | Ser/Plas.ultracentrifugate | Qn | Cholesterol in HDL [Mass/volume] in Serum or Plasma ultracentrifugate | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
| 1.000.333 | Lipids | HDL Cholesterol | 14646-4 | Cholesterol.in HDL | SCnc | Pt | Ser/Plas | Qn | Cholesterol in HDL [Moles/volume] in Serum or Plasma | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
| 1.000.314 | Lipids | Deprecated LDL Cholesterol | 2090-9 | Cholesterol.in LDL | MCnc | Pt | Ser/Plas | Qn | Deprecated Cholesterol.in LDL [Mass/volume] in Serum or Plasma | DEPRECATED | 100% | Active | 102,00 | ||||||||||||
| 1.000.315 | Lipids | LDL Cholesterol | 2089-1 | Cholesterol.in LDL | MCnc | Pt | Ser/Plas | Qn | Cholesterol in LDL [Mass/volume] in Serum or Plasma | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
| 1.000.316 | Lipids | LDL Calculated | 13457-7 | Cholesterol.in LDL | MCnc | Pt | Ser/Plas | Qn | Calculated | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | X | ACTIVE | 100% | Active | 102,00 | ||||||||||
| 1.000.317 | Lipids | LDL Cholesterol Direct Assay | 18262-6 | Cholesterol.in LDL | MCnc | Pt | Ser/Plas | Qn | Direct assay | Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay | X | ACTIVE | 100% | Active | 102,00 | ||||||||||
| 1.000.319 | Lipids | LDL Cholesterol by VAP | 55440-2 | Cholesterol.in LDL | MCnc | Pt | Ser/Plas | Qn | VAP | Cholesterol.in LDL (real) [Mass/volume] in Serum or Plasma by VAP | X | ACTIVE | 100% | Active | 102,00 | ||||||||||
| 1.000.320 | Lipids | LDL Cholesterol Ultracentrifuged | 18261-8 | Cholesterol.in LDL | MCnc | Pt | Ser/Plas.ultracentrifugate | Qn | Cholesterol in LDL [Mass/volume] in Serum or Plasma ultracentrifugate | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
| 1.000.322 | Lipids | LDL Cholesterol | 22748-8 | Cholesterol.in LDL | SCnc | Pt | Ser/Plas | Qn | Cholesterol in LDL [Moles/volume] in Serum or Plasma | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
| 1.000.323 | Lipids | LDL Calculated | 39469-2 | Cholesterol.in LDL | SCnc | Pt | Ser/Plas | Qn | Calculated | Cholesterol in LDL [Moles/volume] in Serum or Plasma by calculation | X | ACTIVE | 100% | Active | 102,00 | ||||||||||
| 1.000.324 | Lipids | LDL Cholesterol Direct Assay | 69419-0 | Cholesterol.in LDL | SCnc | Pt | Ser/Plas | Qn | Direct assay | Cholesterol in LDL [Moles/volume] in Serum or Plasma by Direct assay | X | ACTIVE | 100% | Active | 102,00 | ||||||||||
| 1.000.325 | Lipids | LDL Cholesterol Real Size Pattern | 47213-4 | Cholesterol.in LDL real size pattern | Prid | Pt | Ser/Plas | Nom | Cholesterol in LDL real size pattern [Identifier] in Serum or Plasma | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
| 1.006.054 | Lipids | Lp(a) Cholesterol | 35388-8 | Cholesterol.in lipoprotein (little a) | MCnc | Pt | Ser/Plas | Qn | Cholesterol. in Lipoprotein (a) [Mass/volume] in Serum or Plasma | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
| 1.000.355 | Lipids | Deprecated VLDL | 2092-5 | Cholesterol.in VLDL | MCnc | Pt | Ser/Plas | Qn | Deprecated Cholesterol.in VLDL [Mass/volume] in Serum or Plasma | DEPRECATED | 100% | Active | 102,00 | ||||||||||||
| 1.000.356 | Lipids | VLDL | 2091-7 | Cholesterol.in VLDL | MCnc | Pt | Ser/Plas | Qn | Cholesterol in VLDL [Mass/volume] in Serum or Plasma | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
| 1.000.357 | Lipids | VLDL Calculated | 13458-5 | Cholesterol.in VLDL | MCnc | Pt | Ser/Plas | Qn | Calculated | Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation | X | ACTIVE | 100% | Active | 102,00 | ||||||||||
| 1.000.358 | Lipids | VLDL by Electrophoresis | 49133-2 | Cholesterol.in VLDL | MCnc | Pt | Ser/Plas | Qn | Electrophoresis | Cholesterol in VLDL [Mass/volume] in Serum or Plasma by Electrophoresis | X | ACTIVE | 100% | Active | 102,00 | ||||||||||
| 1.000.359 | Lipids | VLDL Ultracentrifuged | 48618-3 | Cholesterol.in VLDL | MCnc | Pt | Ser/Plas.ultracentrifugate | Qn | Cholesterol in VLDL [Mass/volume] in Serum or Plasma ultracentrifugate | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
| 1.000.360 | Lipids | VLDL | 25371-6 | Cholesterol.in VLDL | SCnc | Pt | Ser/Plas | Qn | Cholesterol in VLDL [Moles/volume] in Serum or Plasma | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
| 1.000.361 | Lipids | VLDL Calculated | 66126-4 | Cholesterol.in VLDL | SCnc | Pt | Ser/Plas | Qn | Calculated | Cholesterol in VLDL [Moles/volume] in Serum or Plasma by calculation | X | ACTIVE | 100% | Active | 102,00 | ||||||||||
| 1.000.352 | Lipids | Non-HDL Cholesterol | 43396-1 | Cholesterol.non HDL | MCnc | Pt | Ser/Plas | Qn | Cholesterol non HDL [Mass/volume] in Serum or Plasma | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
| 1.000.353 | Lipids | Non-HDL Cholesterol | 70204-3 | Cholesterol.non HDL | SCnc | Pt | Ser/Plas | Qn | Cholesterol non HDL [Moles/volume] in Serum or Plasma | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
| 1.006.056 | Lipids | Lipoprotein a Lp(a) | 10835-7 | Lipoprotein (little a) | MCnc | Pt | Ser/Plas | Qn | Lipoprotein a [Mass/volume] in Serum or Plasma | X | X | ACTIVE | 100% | Active | 102,00 | ||||||||||
| 1.006.057 | Lipids | Lipoprotein a Lp(a) | 43583-4 | Lipoprotein (little a) | SCnc | Pt | Ser/Plas | Qn | Lipoprotein a [Moles/volume] in Serum or Plasma | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
| 1.006.102 | Lipids | Lipoprotein Insulin Resistance Score (LP-IR Score) | 62255-5 | Lipoprotein insulin resistance score | Score | Pt | Ser/Plas | Qn | Lipoprotein insulin resistance score in Serum or Plasma | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
| 1.006.061 | Lipids | Alpha Lipoprotein (HDL Particle) Size | 62253-0 | Lipoprotein.alpha | EntLen | Pt | Ser/Plas | Qn | Lipoprotein.alpha [Entitic length] in Serum or Plasma | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
| 1.006.062 | Lipids | Alpha Lipoprotein (HDL Particle) Size | 2573-4 | Lipoprotein.alpha | MCnc | Pt | Ser/Plas | Qn | Lipoprotein.alpha [Mass/volume] in Serum or Plasma | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
| 1.006.064 | Lipids | Alpha Lipoprotein (HDL Particle) Number (HDL-P Total) | 49748-7 | Lipoprotein.alpha | SCnc | Pt | Ser/Plas | Qn | Lipoprotein.alpha [Moles/volume] in Serum or Plasma | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
| 1.006.065 | Lipids | Alpha Lipoprotein (HDL Particle) by Electrophoresis | 14813-0 | Lipoprotein.alpha | SCnc | Pt | Ser/Plas | Qn | Electrophoresis | Lipoprotein.alpha [Moles/volume] in Serum or Plasma by Electrophoresis | X | ACTIVE | 83% | Active | 102,00 | ||||||||||
| 1.006.066 | Lipids | Alpha 3 Lipoprotein (HDL Medium Particle) Size | 86222-7 | Lipoprotein.alpha 3 | SCnc | Pt | Ser | Qn | Lipoprotein.alpha 3 [Moles/volume] in Serum | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
| 1.006.067 | Lipids | Alpha Lipoprotein (Large HDL Particle) Number (HDL-P) | 43729-3 | Lipoprotein.alpha.subparticle.large | SCnc | Pt | Ser/Plas | Qn | Lipoprotein.alpha.subparticle.large [Moles/volume] in Serum or Plasma | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
| 1.006.068 | Lipids | Alpha Lipoprotein (Small HDL Particle) Number (HDL-P) | 92711-1 | Lipoprotein.alpha.subparticle.small | SCnc | Pt | Ser | Qn | Lipoprotein.alpha.subparticle.small [Moles/volume] in Serum | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
| 1.006.069 | Lipids | Alpha Lipoprotein (HDL Particle) / Total Lipoprotein | 15121-7 | Lipoprotein.alpha/Lipoprotein.total | MFr | Pt | Ser/Plas | Qn | Lipoprotein.alpha/total Lipoprotein in Serum or Plasma | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
| 1.006.070 | Lipids | Beta Lipoprotein (LDL Particle) | 2574-2 | Lipoprotein.beta | MCnc | Pt | Ser/Plas | Qn | Lipoprotein.beta [Mass/volume] in Serum or Plasma | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
| 1.006.071 | Lipids | Beta Lipoprotein (LDL Particle) by Calculation | 9346-8 | Lipoprotein.beta | MCnc | Pt | Ser/Plas | Qn | Calculated | Lipoprotein.beta [Mass/volume] in Serum or Plasma by calculation | X | ACTIVE | 83% | Active | 102,00 | ||||||||||
| 1.006.073 | Lipids | Beta Lipoprotein (LDL Particle) by Calculation | 14815-5 | Lipoprotein.beta | SCnc | Pt | Ser/Plas | Qn | Calculated | Lipoprotein.beta [Moles/volume] in Serum or Plasma by calculation | X | ACTIVE | 83% | Active | 102,00 | ||||||||||
| 1.006.074 | Lipids | Beta Lipoprotein (LDL Particle) by Electrophoresis | 14814-8 | Lipoprotein.beta | SCnc | Pt | Ser/Plas | Qn | Electrophoresis | Lipoprotein.beta [Moles/volume] in Serum or Plasma by Electrophoresis | X | ACTIVE | 83% | Active | 102,00 | ||||||||||
| 1.006.075 | Lipids | Beta Lipoprotein (LDL Subparticle) Size | 17782-4 | Lipoprotein.beta.subparticle | EntLen | Pt | Ser/Plas | Qn | Lipoprotein.beta.subparticle [Entitic length] in Serum or Plasma | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
| 1.006.076 | Lipids | Beta Lipoprotein (LDL Subparticle) Number (LDL-P) | 54434-6 | Lipoprotein.beta.subparticle | SCnc | Pt | Ser/Plas | Qn | Lipoprotein.beta.subparticle [Moles/volume] in Serum or Plasma | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
| 1.006.077 | Lipids | Beta Lipoprotein (LDL Subparticle) Type | 35505-7 | Lipoprotein.beta.subparticle | Type | Pt | Ser/Plas | Nom | Lipoprotein.beta.subparticle [Type] in Serum or Plasma | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
| 1.006.078 | Lipids | Beta Lipoprotein (Intermediate LDL Subparticle) Size | 47215-9 | Lipoprotein.beta.subparticle.intermediate | EntLen | Pt | Ser/Plas | Qn | Lipoprotein.beta.subparticle.intermediate [Entitic length] in Serum or Plasma | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
| 1.006.079 | Lipids | Beta Lipoprotein (Large A LDL Subparticle) Size | 92717-8 | Lipoprotein.beta.subparticle.large-a | SCnc | Pt | Ser | Qn | Lipoprotein.beta.subparticle.large-a [Moles/volume] in Serum | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
| 1.006.080 | Lipids | Beta Lipoprotein (Large B LDL Subparticle) Size | 92716-0 | Lipoprotein.beta.subparticle.large-b | SCnc | Pt | Ser | Qn | Lipoprotein.beta.subparticle.large-b [Moles/volume] in Serum | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
| 1.006.081 | Lipids | Beta Lipoprotein (Small LDL Subparticle) Number (LDL-P) | 43727-7 | Lipoprotein.beta.subparticle.small | SCnc | Pt | Ser/Plas | Qn | Lipoprotein.beta.subparticle.small [Moles/volume] in Serum or Plasma | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
| 1.006.082 | Lipids | Beta Lipoprotein (Very Small A LDL Subparticle) Number (LDL-P) | 92715-2 | Lipoprotein.beta.subparticle.very small-a | SCnc | Pt | Ser | Qn | Lipoprotein.beta.subparticle.very small-a [Moles/volume] in Serum | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
| 1.006.083 | Lipids | Beta Lipoprotein (Very Small B LDL Subparticle) Number (LDL-P) | 92714-5 | Lipoprotein.beta.subparticle.very small-b | SCnc | Pt | Ser | Qn | Lipoprotein.beta.subparticle.very small-b [Moles/volume] in Serum | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
| 1.006.084 | Lipids | Beta Lipoprotein (Very Small C LDL Subparticle) Number (LDL-P) | 92713-7 | Lipoprotein.beta.subparticle.very small-c | SCnc | Pt | Ser | Qn | Lipoprotein.beta.subparticle.very small-c [Moles/volume] in Serum | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
| 1.006.085 | Lipids | Beta Lipoprotein (Very Small D LDL Subparticle) Number (LDL-P) | 92712-9 | Lipoprotein.beta.subparticle.very small-d | SCnc | Pt | Ser | Qn | Lipoprotein.beta.subparticle.very small-d [Moles/volume] in Serum | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
| 1.006.086 | Lipids | Beta Lipoprotein (LDL Particle) / Alpha Lipoprotein (HDL Particle) | 44717-7 | Lipoprotein.beta/Lipoprotein.alpha | MRto | Pt | Ser/Plas | Qn | Lipoprotein.beta/Lipoprotein.alpha [Mass Ratio] in Serum or Plasma | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
| 1.006.087 | Lipids | Beta Lipoprotein (LDL Particle) / Total Lipoprotein | 15122-5 | Lipoprotein.beta/Lipoprotein.total | MFr | Pt | Ser/Plas | Qn | Lipoprotein.beta/total Lipoprotein in Serum or Plasma | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
| 1.006.088 | Lipids | Beta Lipoprotein (Large Broad LDL Subparticle) Size | 92719-4 | Lipoprotein.broad beta.subparticle.large | SCnc | Pt | Ser | Qn | Lipoprotein.broad beta.subparticle.large [Moles/volume] in Serum | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
| 1.006.089 | Lipids | Beta Lipoprotein (Small Broad LDL Subparticle) Size | 92718-6 | Lipoprotein.broad beta.subparticle.small | SCnc | Pt | Ser | Qn | Lipoprotein.broad beta.subparticle.small [Moles/volume] in Serum | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
| 1.006.091 | Lipids | Pre Beta Lipoprotein (VLDL Particle) Size (VLDL-P) | 62254-8 | Lipoprotein.pre-beta | EntLen | Pt | Ser/Plas | Qn | Lipoprotein.pre-beta [Entitic length] in Serum or Plasma | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
| 1.006.092 | Lipids | Pre Beta Lipoprotein (VLDL Particle) | 2575-9 | Lipoprotein.pre-beta | MCnc | Pt | Ser/Plas | Qn | Lipoprotein.pre-beta [Mass/volume] in Serum or Plasma | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
| 1.006.094 | Lipids | Pre Beta Lipoprotein (VLDL Particle) by Electrophoresis | 14816-3 | Lipoprotein.pre-beta | SCnc | Pt | Ser/Plas | Qn | Electrophoresis | Lipoprotein.pre-beta [Moles/volume] in Serum or Plasma by Electrophoresis | X | ACTIVE | 83% | Active | 102,00 | ||||||||||
| 1.006.095 | Lipids | Pre Beta Lipoprotein (Large VLDL Subparticle) Number | 43728-5 | Lipoprotein.pre-beta.subparticle.large | SCnc | Pt | Ser/Plas | Qn | Lipoprotein.pre-beta.subparticle.large [Moles/volume] in Serum or Plasma | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
| 1.006.096 | Lipids | Pre Beta Lipoprotein (Medium VLDL Subparticle) Number | 92721-0 | Lipoprotein.pre-beta.subparticle.medium | SCnc | Pt | Ser | Qn | Lipoprotein.pre-beta.subparticle.medium [Moles/volume] in Serum | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
| 1.006.097 | Lipids | Pre Beta Lipoprotein (Small VLDL Subparticle) Number | 92720-2 | Lipoprotein.pre-beta.subparticle.small | SCnc | Pt | Ser | Qn | Lipoprotein.pre-beta.subparticle.small [Moles/volume] in Serum | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
| 1.006.098 | Lipids | Pre Beta Lipoprotein (VLDL Particle) / Beta Lipoprotein (LDL Particle) | 56777-6 | Lipoprotein.pre-beta/Lipoprotein.beta | MRto | Pt | Ser/Plas | Qn | Lipoprotein.pre-beta/Lipoprotein.beta [Mass Ratio] in Serum or Plasma | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
| 1.006.099 | Lipids | Pre Beta Lipoprotein (VLDL Particle) / Total Lipoprotein | 15123-3 | Lipoprotein.pre-beta/Lipoprotein.total | MFr | Pt | Ser/Plas | Qn | Lipoprotein.pre-beta/total Lipoprotein in Serum or Plasma | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
| 1.006.100 | Lipids | Pre Beta Lipoprotein (VLDL Particle) / Triglyceride | 44718-5 | Lipoprotein.pre-beta/Triglyceride | MRto | Pt | Ser/Plas | Qn | Lipoprotein.pre-beta/Triglyceride [Mass Ratio] in Serum or Plasma | X | ACTIVE | 83% | Active | 102,00 | |||||||||||
| 1.000.339 | Lipids | Triglycerides | 2571-8 | Triglyceride | MCnc | Pt | Ser/Plas | Qn | Triglyceride [Mass/volume] in Serum or Plasma | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
| 1.000.340 | Lipids | Triglycerides Calculated | 12951-0 | Triglyceride | MCnc | Pt | Ser/Plas | Qn | Calculated | Triglyceride [Mass/volume] in Serum or Plasma by calculation | X | ACTIVE | 100% | Active | 102,00 | ||||||||||
| 1.000.343 | Lipids | Triglycerides | 14927-8 | Triglyceride | SCnc | Pt | Ser/Plas | Qn | Triglyceride [Moles/volume] in Serum or Plasma | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
| 1.000.349 | Lipids | Triglycerides Blood | 3043-7 | Triglyceride | MCnc | Pt | Bld | Qn | Triglyceride [Mass/volume] in Blood | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
| 1.000.350 | Lipids | Triglycerides Blood | 70218-3 | Triglyceride | SCnc | Pt | Bld | Qn | Triglyceride [Moles/volume] in Blood | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
| 1.000.344 | Lipids | Triglycerides 12 Hours Fasting | 1644-4 | Triglyceride^post 12H CFst | MCnc | Pt | Ser/Plas | Qn | Triglyceride [Mass/volume] in Serum or Plasma --12 hours fasting | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
| 1.000.345 | Lipids | Triglycerides 12 Hours Fasting | 30524-3 | Triglyceride^post 12H CFst | SCnc | Pt | Ser/Plas | Qn | Triglyceride [Moles/volume] in Serum or Plasma --12 hours fasting | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
| 1.000.346 | Lipids | Deprecated Triglycerides Fasting | 17081-1 | Triglyceride^post CFst | MCnc | Pt | Ser | Qn | Deprecated Triglyceride [Mass/volume] in Serum or Plasma --post CFst | DEPRECATED | 100% | Active | 102,00 | ||||||||||||
| 1.000.347 | Lipids | Triglycerides Fasting | 3048-6 | Triglyceride^post CFst | MCnc | Pt | Ser/Plas | Qn | Triglyceride [Mass/volume] in Serum or Plasma --fasting | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
| 1.000.348 | Lipids | Triglycerides Fasting | 47210-0 | Triglyceride^post CFst | SCnc | Pt | Ser/Plas | Qn | Triglyceride [Moles/volume] in Serum or Plasma --fasting | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
| 1.011.074 | Lipids | NMR Profile Report | NA | NA | NA | NA | NA | NA | NA | NA | X | NA | Interpretations, Comments, Notes, etc. associated this lab test may require manual inclusion due to variety of ways represented. | 83% | Active | 102,00 | |||||||||
| 1.000.414 | Cardiac Tests | CRP Blood High Sensitivity | 71426-1 | C reactive protein | MCnc | Pt | Bld | Qn | High sensitivity | C reactive protein [Mass/volume] in Blood by High sensitivity method | X | ACTIVE | 100% | Active | 102,00 | ||||||||||
| 1.000.417 | Cardiac Tests | CRP High Sensitivity | 30522-7 | C reactive protein | MCnc | Pt | Ser/Plas | Qn | High sensitivity | C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method | X | X | ACTIVE | 100% | Active | 102,00 | |||||||||
| 1.000.421 | Cardiac Tests | CRP High Sensitivity | 76486-0 | C reactive protein | SCnc | Pt | Ser/Plas | Qn | High sensitivity | C reactive protein [Moles/volume] in Serum or Plasma by High sensitivity method | X | ACTIVE | 100% | Active | 102,00 | ||||||||||
| 1.002.907 | Diabetes Tests | HgbA1c | 41995-2 | Hemoglobin A1c | MCnc | Pt | Bld | Qn | Hemoglobin A1c [Mass/volume] in Blood | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
| 1.002.908 | Diabetes Tests | HgbA1c | 4548-4 | Hemoglobin A1c/Hemoglobin.total | MFr | Pt | Bld | Qn | Hemoglobin A1c/Hemoglobin.total in Blood | X | X | ACTIVE | 100% | Active | 102,00 | ||||||||||
| 1.002.909 | Diabetes Tests | HgbA1c Calculated | 17855-8 | Hemoglobin A1c/Hemoglobin.total | MFr | Pt | Bld | Qn | Calculated | Hemoglobin A1c/Hemoglobin.total in Blood by calculation | X | ACTIVE | 100% | Active | 102,00 | ||||||||||
| 1.002.910 | Diabetes Tests | HgbA1c by Electrophoresis | 4549-2 | Hemoglobin A1c/Hemoglobin.total | MFr | Pt | Bld | Qn | Electrophoresis | Hemoglobin A1c/Hemoglobin.total in Blood by Electrophoresis | X | ACTIVE | 100% | Active | 102,00 | ||||||||||
| 1.002.911 | Diabetes Tests | HgbA1c by HPLC | 17856-6 | Hemoglobin A1c/Hemoglobin.total | MFr | Pt | Bld | Qn | HPLC | Hemoglobin A1c/Hemoglobin.total in Blood by HPLC | X | X | ACTIVE | 100% | Active | 102,00 | |||||||||
| 1.002.912 | Diabetes Tests | HgbA1c by JDS/JSCC Protocol | 62388-4 | Hemoglobin A1c/Hemoglobin.total | MFr | Pt | Bld | Qn | JDS/JSCC | Hemoglobin A1c/Hemoglobin.total in Blood by JDS/JSCC protocol | X | ACTIVE | 100% | Active | 102,00 | ||||||||||
| 1.002.913 | Diabetes Tests | HgbA1c | 71875-9 | Hemoglobin A1c/Hemoglobin.total | MFr.DF | Pt | Bld | Qn | Hemoglobin A1c/Hemoglobin.total [Pure mass fraction] in Blood | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
| 1.002.914 | Diabetes Tests | HgbA1c by IFCC Protocol | 59261-8 | Hemoglobin A1c/Hemoglobin.total | SFr | Pt | Bld | Qn | IFCC | Hemoglobin A1c/Hemoglobin.total in Blood by IFCC protocol | X | ACTIVE | 100% | Active | 102,00 | ||||||||||
| 1.003.325 | Endocrine Tests | Thyrotropin (TSH) Blood | 3015-5 | Thyrotropin | ACnc | Pt | Bld | Qn | Thyrotropin [Units/volume] in Blood | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
| 1.003.327 | Endocrine Tests | Thyrotropin (TSH) | 3016-3 | Thyrotropin | ACnc | Pt | Ser/Plas | Qn | Thyrotropin [Units/volume] in Serum or Plasma | X | X | ACTIVE | 100% | Active | 102,00 | ||||||||||
| 1.003.328 | Endocrine Tests | Thyrotropin (TSH) | 11580-8 | Thyrotropin | ACnc | Pt | Ser/Plas | Qn | Detection limit <= 0.005 mIU/L | Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.005 mIU/L | X | ACTIVE | 100% | Active | 102,00 | ||||||||||
| 1.003.329 | Endocrine Tests | Thyrotropin (TSH) | 11579-0 | Thyrotropin | ACnc | Pt | Ser/Plas | Qn | Detection limit <= 0.05 mIU/L | Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L | X | X | ACTIVE | 100% | Active | 102,00 | |||||||||
| 1.003.330 | Endocrine Tests | Thyrotropin (TSH) (Discouraged) | 27975-2 | Thyrotropin | MCnc | Pt | Ser/Plas | Qn | Thyrotropin [Mass/volume] in Serum or Plasma | DISCOURAGED | 100% | Active | 102,00 | ||||||||||||
| 1.003.331 | Endocrine Tests | Thyrotropin (TSH) (Discouraged) | 14297-6 | Thyrotropin | SCnc | Pt | Ser/Plas | Qn | Thyrotropin [Moles/volume] in Serum or Plasma | DISCOURAGED | 100% | Active | 102,00 | ||||||||||||
| 1.003.348 | Endocrine Tests | Thyrotropin (TSH) 15 Mins Pre Dose Luteinizing Releasing Hormone IV | 47949-3 | Thyrotropin^15M pre dose lutenizing releasing hormone IV | ACnc | Pt | Ser/Plas | Qn | Thyrotropin [Units/volume] in Serum or Plasma --15 minutes pre dose lutenizing releasing hormone IV | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
| 1.003.347 | Endocrine Tests | Thyrotropin (TSH) 15 Mins Pre Dose TRH IV | 44936-3 | Thyrotropin^15M pre dose TRH IV | ACnc | Pt | Ser/Plas | Qn | Thyrotropin [Units/volume] in Serum or Plasma --15 minutes pre dose TRH IV | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
| 1.003.397 | Endocrine Tests | Thyrotropin (TSH) Baseline | 14999-7 | Thyrotropin^baseline | ACnc | Pt | Ser/Plas | Qn | Thyrotropin [Units/volume] in Serum or Plasma --baseline | X | X | ACTIVE | 100% | Active | 102,00 | ||||||||||
| 1.003.398 | Endocrine Tests | Thyrotropin (TSH) Baseline (Discouraged) | 1642-8 | Thyrotropin^baseline | MCnc | Pt | Ser/Plas | Qn | Thyrotropin [Mass/volume] in Serum or Plasma --baseline | DISCOURAGED | 100% | Active | 102,00 | ||||||||||||
| 1.003.406 | Endocrine Tests | Thyrotropin (TSH) Pre Dose Luteinizing Releasing Hormone IV | 47953-5 | Thyrotropin^pre dose lutenizing releasing hormone IV | ACnc | Pt | Ser/Plas | Qn | Thyrotropin [Units/volume] in Serum or Plasma --pre dose lutenizing releasing hormone IV | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
| 1.003.401 | Endocrine Tests | Thyrotropin (TSH) Pre Dose TRH | 33269-2 | Thyrotropin^pre dose TRH | ACnc | Pt | Ser/Plas | Qn | Thyrotropin [Units/volume] in Serum or Plasma --pre dose TRH | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
| 1.003.402 | Endocrine Tests | Thyrotropin (TSH) Pre Dose TRH IN (Discouraged) | 25991-1 | Thyrotropin^pre dose TRH IN | SCnc | Pt | Ser/Plas | Qn | Thyrotropin [Moles/volume] in Serum or Plasma --pre dose TRH IN | DISCOURAGED | 100% | Active | 102,00 | ||||||||||||
| 1.003.403 | Endocrine Tests | Deprecated Thyrotropin (TSH) Pre Dose TRH IN | 44937-1 | Thyrotropin^pre dose TRH IV | ACnc | Pt | Ser/Plas | Qn | Deprecated Thyrotropin [Units/volume] in Serum or Plasma --pre dose TRH IV | DEPRECATED | 100% | Active | 102,00 | ||||||||||||
| 1.003.404 | Endocrine Tests | Thyrotropin (TSH) Pre Dose TRH IV | 15000-3 | Thyrotropin^pre dose TRH IV | ACnc | Pt | Ser/Plas | Qn | Thyrotropin [Units/volume] in Serum or Plasma --pre dose TRH IV | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
| 1.003.405 | Endocrine Tests | Thyrotropin (TSH) Pre Dose TRH IV (Discouraged) | 1643-6 | Thyrotropin^pre dose TRH IV | MCnc | Pt | Ser/Plas | Qn | Thyrotropin [Mass/volume] in Serum or Plasma --pre dose TRH IV | DISCOURAGED | 100% | Active | 102,00 | ||||||||||||
| 1.003.407 | Endocrine Tests | Thyrotropin (TSH) Pre Dose Triple Bolus | 40401-2 | Thyrotropin^pre dose triple bolus | ACnc | Pt | Ser/Plas | Qn | Thyrotropin [Units/volume] in Serum or Plasma --pre dose triple bolus | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
| 1.000.362 | Other Blood Chemistry Tests | CK | 2157-6 | Creatine kinase | CCnc | Pt | Ser/Plas | Qn | Creatine kinase [Enzymatic activity/volume] in Serum or Plasma | X | X | ACTIVE | 100% | Active | 102,00 | ||||||||||
| 1.000.363 | Other Blood Chemistry Tests | CK (Discouraged) | 50756-6 | Creatine kinase | MCnc | Pt | Bld | Qn | Creatine kinase [Mass/volume] in Blood | DISCOURAGED | 100% | Active | 102,00 | ||||||||||||
| 1.000.185 | Challenge Tests | Creatinine 1.5 Hours Pre Dose | 39956-8 | Creatinine^1.5H pre XXX challenge | MCnc | Pt | Ser/Plas | Qn | Creatinine [Mass/volume] in Serum or Plasma --1.5 hours pre XXX challenge | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
| 1.000.186 | Challenge Tests | Creatinine 1.5 Hours Pre Dose | 40113-3 | Creatinine^1.5H pre XXX challenge | SCnc | Pt | Ser/Plas | Qn | Creatinine [Moles/volume] in Serum or Plasma --1.5 hours pre XXX challenge | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
| 1.000.200 | Challenge Tests | Creatinine 1 Hour Pre Dose | 39957-6 | Creatinine^1H pre XXX challenge | MCnc | Pt | Ser/Plas | Qn | Creatinine [Mass/volume] in Serum or Plasma --1 hour pre XXX challenge | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
| 1.000.201 | Challenge Tests | Creatinine 1 Hour Pre Dose | 40114-1 | Creatinine^1H pre XXX challenge | SCnc | Pt | Ser/Plas | Qn | Creatinine [Moles/volume] in Serum or Plasma --1 hour pre XXX challenge | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
| 1.000.216 | Challenge Tests | Creatinine 30 Mins Pre Dose | 39959-2 | Creatinine^30M pre XXX challenge | MCnc | Pt | Ser/Plas | Qn | Creatinine [Mass/volume] in Serum or Plasma --30 minutes pre XXX challenge | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
| 1.000.217 | Challenge Tests | Creatinine 30 Mins Pre Dose | 40116-6 | Creatinine^30M pre XXX challenge | SCnc | Pt | Ser/Plas | Qn | Creatinine [Moles/volume] in Serum or Plasma --30 minutes pre XXX challenge | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
| 1.000.223 | Challenge Tests | Creatinine 45 Mins Pre Dose | 39958-4 | Creatinine^45M pre XXX challenge | MCnc | Pt | Ser/Plas | Qn | Creatinine [Mass/volume] in Serum or Plasma --45 minutes pre XXX challenge | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
| 1.000.224 | Challenge Tests | Creatinine 45 Mins Pre Dose | 40115-8 | Creatinine^45M pre XXX challenge | SCnc | Pt | Ser/Plas | Qn | Creatinine [Moles/volume] in Serum or Plasma --45 minutes pre XXX challenge | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
| 1.000.243 | Challenge Tests | Creatinine Baseline | 40248-7 | Creatinine^baseline | MCnc | Pt | Ser/Plas | Qn | Creatinine [Mass/volume] in Serum or Plasma --baseline | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
| 1.000.244 | Challenge Tests | Creatinine Baseline | 40264-4 | Creatinine^baseline | SCnc | Pt | Ser/Plas | Qn | Creatinine [Moles/volume] in Serum or Plasma --baseline | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
| 1.000.248 | Challenge Tests | Creatinine Pre Dose | 39955-0 | Creatinine^pre XXX challenge | MCnc | Pt | Ser/Plas | Qn | Creatinine [Mass/volume] in Serum or Plasma --pre XXX challenge | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
| 1.000.249 | Challenge Tests | Creatinine Pre Dose | 40112-5 | Creatinine^pre XXX challenge | SCnc | Pt | Ser/Plas | Qn | Creatinine [Moles/volume] in Serum or Plasma --pre XXX challenge | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
| 1.003.346 | Challenge Tests | Thyrotropin (TSH) 15 Mins Pre Challenge | 58834-3 | Thyrotropin^15M pre XXX challenge | ACnc | Pt | Ser/Plas | Qn | Thyrotropin [Units/volume] in Serum or Plasma --15 minutes pre XXX challenge | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
| 1.003.363 | Challenge Tests | Thyrotropin (TSH) 20 Mins Pre Challenge (Discouraged) | 58833-5 | Thyrotropin^20M pre XXX challenge | MCnc | Pt | Ser/Plas | Qn | Thyrotropin [Mass/volume] in Serum or Plasma --20 minutes pre XXX challenge | DISCOURAGED | 100% | Active | 102,00 | ||||||||||||
| 1.003.377 | Challenge Tests | Thyrotropin (TSH) 30 Mins Pre Challenge | 12940-3 | Thyrotropin^30M pre XXX challenge | ACnc | Pt | Ser/Plas | Qn | Thyrotropin [Units/volume] in Serum or Plasma --30 minutes pre XXX challenge | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
| 1.003.400 | Challenge Tests | Thyrotropin (TSH) Pre Challenge | 55362-8 | Thyrotropin^pre XXX challenge | ACnc | Pt | Ser/Plas | Qn | Thyrotropin [Units/volume] in Serum or Plasma --pre XXX challenge | X | ACTIVE | 100% | Active | 102,00 | |||||||||||
| Associated Problem ID | Associated Problem Name | Data Domain | Coding System | Coding System Version | Lab Primary Key | Clinical Category | Result Name | LOINC Code | LOINC Component | LOINC Property | LOINC Time | LOINC System | LOINC Scale | LOINC Method | LOINC Long Name | Common US Use | Common Intl Use | Also Consider | LOINC Status | External Comments | PCM Status | Release Change Comments | PCM Version First Released | PCM Version Last Updated |
Medications
| Associated Problem ID | Associated Problem Name | Data Domain | Coding System | Coding System Version | Med Primary Key | Category | RxNorm Subclass | Medication | RxNorm Code | Term Type | Exclude Routes | NCI Code | International Use | External Comments | PCM Status | % Consensus Agreement | Release Change Comments | PCM Version First Released | PCM Version Last Updated |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.008 | Dyslipidemia | Medications | RxNorm | 01/12/2019 | 1.001.096 | Anti-Hyperlipidemics | Antilipemic Agents | omega-3 acid ethyl esters (USP) | 484348 | IN | Active | 100% | 102,00 | 1.02 | |||||
| 1.001.084 | Anti-Hyperlipidemics | Bile Acid Sequestrants | cholestyramine resin | 2447 | IN | Active | 100% | 102,00 | 1.02 | ||||||||||
| 1.001.431 | Anti-Hyperlipidemics | Bile Acid Sequestrants | colesevelam | 141626 | IN | Active | 100% | 102,00 | 1.02 | ||||||||||
| 1.001.432 | Anti-Hyperlipidemics | Bile Acid Sequestrants | colestipol | 2685 | IN | Active | 100% | 102,00 | 1.02 | ||||||||||
| 1.001.093 | Anti-Hyperlipidemics | Combinations of Various Lipid Modifying Agents | atorvastatin / ezetimibe | 1422085 | MIN | Active | 100% | Field Updated (RxNorm Subclass) | 102,00 | 1.02.1 | |||||||||
| 1.001.094 | Anti-Hyperlipidemics | Combinations of Various Lipid Modifying Agents | ezetimibe / simvastatin | 484211 | MIN | Active | 100% | Field Updated (RxNorm Subclass) | 102,00 | 1.02.1 | |||||||||
| 1.001.078 | Anti-Hyperlipidemics | Combinations of Various Lipid Modifying Agents | lovastatin / niacin | 352387 | MIN | Active | 100% | Field Updated (RxNorm Subclass) | 102,00 | 1.02.1 | |||||||||
| 1.001.079 | Anti-Hyperlipidemics | Combinations of Various Lipid Modifying Agents | niacin / simvastatin | 803516 | MIN | Active | 100% | Field Updated (RxNorm Subclass) | 102,00 | 1.02.1 | |||||||||
| 1.001.087 | Anti-Hyperlipidemics | Fibrates | choline fenofibrate | 1433887 | IN | Active | 100% | 102,00 | 1.02 | ||||||||||
| 1.001.088 | Anti-Hyperlipidemics | Fibrates | fenofibrate | 8703 | IN | Active | 100% | 102,00 | 1.02 | ||||||||||
| 1.001.091 | Anti-Hyperlipidemics | Fibrates | gemfibrozil | 4719 | IN | Active | 100% | 102,00 | 1.02 | ||||||||||
| 1.001.433 | Anti-Hyperlipidemics | HMG CoA Reductase Inhibitors | atorvastatin | 83367 | IN | Active | 100% | Field Updated (RxNorm Subclass) | 102,00 | 1.02.1 | |||||||||
| 1.001.434 | Anti-Hyperlipidemics | HMG CoA Reductase Inhibitors | fluvastatin | 41127 | IN | Active | 100% | Field Updated (RxNorm Subclass) | 102,00 | 1.02.1 | |||||||||
| 1.001.073 | Anti-Hyperlipidemics | HMG CoA Reductase Inhibitors | lovastatin | 6472 | IN | Active | 100% | 102,00 | 1.02 | ||||||||||
| 1.001.435 | Anti-Hyperlipidemics | HMG CoA Reductase Inhibitors | pitavastatin | 861634 | IN | Active | 100% | Field Updated (RxNorm Subclass) | 102,00 | 1.02.1 | |||||||||
| 1.001.436 | Anti-Hyperlipidemics | HMG CoA Reductase Inhibitors | pravastatin | 42463 | IN | Active | 100% | Field Updated (RxNorm Subclass) | 102,00 | 1.02.1 | |||||||||
| 1.001.437 | Anti-Hyperlipidemics | HMG CoA Reductase Inhibitors | rosuvastatin | 301542 | IN | Active | 100% | Field Updated (RxNorm Subclass) | 102,00 | 1.02.1 | |||||||||
| 1.001.077 | Anti-Hyperlipidemics | HMG CoA Reductase Inhibitors | simvastatin | 36567 | IN | Active | 100% | 102,00 | 1.02 | ||||||||||
| 1.006.317 | Anti-Hyperlipidemics | HMG CoA Reductase Inhibitors in Combinations with Anti-Hypertensives | amlodipine / atorvastatin | 404773 | MIN | Active | 100% | Field Updated (RxNorm Subclass) | 102,00 | 1.02.1 | |||||||||
| 1.001.092 | Anti-Hyperlipidemics | Nicotinic Acid and Derivatives | niacin | 7393 | IN | Active | 100% | 102,00 | 1.02 | ||||||||||
| 1.010.933 | Anti-Hyperlipidemics | Other Lipid Modifying Agents | bempedoic acid | 2283403 | IN | Inactive | PCM Team Decision | Entry Inactivated | 102,00 | 1.02.1 | |||||||||
| 1.017.455 | Anti-Hyperlipidemics | Other Lipid Modifying Agents | bempedoic acid | 2282403 | IN | Active | PCM Team Decision | New Entry (PCM) | 1.021,00 | 1.02.1 | |||||||||
| 1.010.934 | Anti-Hyperlipidemics | Other Lipid Modifying Agents | bempedoic acid / ezetimibe | 2283229 | MIN | Active | PCM Team Decision | Fields Updated (Medication,% Consensus Agreement) | 102,00 | 1.02.1 | |||||||||
| 1.001.113 | Anti-Hyperlipidemics | Other Lipid Modifying Agents | beta sitosterol | 47070 | IN | Active | 100% | 102,00 | 1.02 | ||||||||||
| 1.001.082 | Anti-Hyperlipidemics | Other Lipid Modifying Agents | ezetimibe | 341248 | IN | Active | PCM Team Decision | New Entry (PCM) | 1.021,00 | 1.02.1 | |||||||||
| 1.001.438 | Anti-Hyperlipidemics | Other Lipid Modifying Agents | icosapent ethyl | 1304974 | IN | Active | 100% | 102,00 | 1.02 | ||||||||||
| 1.001.439 | Anti-Hyperlipidemics | Other Lipid Modifying Agents | lomitapide | 1364479 | IN | Active | 100% | 102,00 | 1.02 | ||||||||||
| 1.001.440 | Anti-Hyperlipidemics | Other Lipid Modifying Agents | mipomersen | 1367839 | IN | Active | 100% | 102,00 | 1.02 | ||||||||||
| 1.001.114 | Anti-Hyperlipidemics | Other Lipid Modifying Agents | plant stanol ester | 259320 | IN | Active | 100% | 102,00 | 1.02 | ||||||||||
| 1.001.441 | Anti-Hyperlipidemics | Other Lipid Modifying Agents | policosanol | 69440 | IN | Active | 83% | Fields Updated (RxNorm Code,Term Type) | 102,00 | 1.02.1 | |||||||||
| 1.001.442 | Anti-Hyperlipidemics | Other Lipid Modifying Agents | probucol | 8699 | IN | X | Active | 83% | Field Updated (International Use) | 102,00 | 1.02.1 | ||||||||
| 1.001.080 | Anti-Hyperlipidemics | Proprotein Convertase Subtilisin / Kexin Type 9 (PCSK9) Inhibitors | alirocumab | 1659152 | IN | Active | 100% | Field Updated (RxNorm Subclass) | 102,00 | 1.02.1 | |||||||||
| 1.001.081 | Anti-Hyperlipidemics | Proprotein Convertase Subtilisin / Kexin Type 9 (PCSK9) Inhibitors | evolocumab | 1665684 | IN | Active | 100% | Field Updated (RxNorm Subclass) | 102,00 | 1.02.1 | |||||||||
| 1.001.444 | Gastrointestinal Agents | Bulk Laxatives | psyllium | 8928 | IN | Active | 100% | 102,00 | 1.02 | ||||||||||
| Associated Problem ID | Associated Problem Name | Data Domain | Coding System | Coding System Version | Med Primary Key | Category | RxNorm Subclass | Medication | RxNorm Code | Term Type | Exclude Routes | NCI Code | International Use | External Comments | PCM Status | % Consensus Agreement | Release Change Comments | PCM Version First Released | PCM Version Last Updated |
Definition
All Problems on this web site are defined as a set of SNOMED CT codes. To view a term and its descendants, go to the International SNOMED site. Then, if in the United States, see LOCAL EXTENSIONS and select the US Browser. Enter the term number or name.
Problems with the following codes (and their descendants) will trigger the map according to the logic listed.
| Associated Problem ID | Associated Problem Name | Data Domain | Coding System | Coding System Version | Row | Include Descendants? | Clinical Name | SNOMED CT Fully Specified Name (FSN) | SNOMED CT | Logic |
|---|---|---|---|---|---|---|---|---|---|---|
| 1.008 | Dyslipidemia | Definition | SNOMED CT | 01/07/2019 | 1 | Y | Disorder of lipoprotein storage and metabolism | Disorder of lipoprotein storage and metabolism (disorder) | 238037008 | (1 OR 2 OR 3 OR 4 OR 5 OR 6 OR 7 OR 8 OR 9 OR 10 OR 11 OR 12 OR 13 OR 14) AND NOT (15) |
| 2 | Y | Dyslipidemia | Dyslipidemia (disorder) | 370992007 | ||||||
| 3 | Y | Hypolipoproteinemia | Hypolipoproteinemia (disorder) | 363140000 | ||||||
| 4 | Y | Lipoprotein deficiency disorder | Lipoprotein deficiency disorder (disorder) | 267436001 | ||||||
| 5 | Y | Inborn error of lipoprotein metabolism | Inborn error of lipoprotein metabolism (disorder) | 43465001 | ||||||
| 6 | Y | Cholesterol level - finding | Finding of cholesterol level (finding) | 365793008 | ||||||
| 7 | Y | Hyperlipidemia | Hyperlipidemia (disorder) | 55822004 | ||||||
| 8 | Y | Increased lipoprotein | Increased lipoprotein (finding) | 124040006 | ||||||
| 9 | Y | Increased cholesterol esters | Increased cholesterol esters (finding) | 124054003 | ||||||
| 10 | Y | Decreased lipoprotein | Decreased lipoprotein (finding) | 124041005 | ||||||
| 11 | Y | Decreased cholesterol esters | Decreased cholesterol esters (finding) | 124055002 | ||||||
| 12 | Y | Lipoprotein electrophoresis abnormal | Lipoprotein electrophoresis abnormal (finding) | 166853009 | ||||||
| 13 | Y | Serum lipid levels - finding | Finding of serum lipid levels (finding) | 365798004 | ||||||
| 14 | Y | Triglyceride level finding | Finding of triglyceride level (finding) | 365795001 | ||||||
| 15 | Y | Serum sodium valproate level | Finding of erum sodium valproate level (finding) | 365746001 |
Copyright © 2016-2020. Board of Regents of the University of Wisconsin System. All rights reserved.